Do outcomes of ureteroscopic stone treatment vary with stone composition? A prospective analysis
- PMID: 36794032
- PMCID: PMC9903168
- DOI: 10.5173/ceju.2022.185
Do outcomes of ureteroscopic stone treatment vary with stone composition? A prospective analysis
Abstract
Introduction: Urinary tract calculi are commonly treated with ureteroscopy and laser stone fragmentation (URSL). The composition of calculi depends on underlying patient factors. Stones associated with metabolic or infectious conditions are sometimes thought to be more difficult to treat. This analysis explores whether the composition of calculi impacts on stone-free and complication rates.
Material and methods: A prospectively maintained database of patients undergoing URSL between 2012-2021 was used to explore records for patients with uric acid (Group A), infection (Group B) and calcium oxalate monohydrate (Group C) calculi. Patients who had undergone URSL to treat ureteric or renal calculi were included. Patient demographics, stone parameters and operative details were collected, with the principal outcomes being stone-free rate (SFR) and associated complications.
Results: A total of 352 patients were included (58 Group A, 71 Group B and 223 Group C patients) and had their data analysed. SFR was >90% for all three groups and a single Clavien-Dindo grade III complication was noted. No significant differences were found between the groups for complications, SFR and day case rates.
Conclusions: This cohort of patients demonstrated that outcomes were similar for three different types of urinary tract calculi, which form for differing reasons. URSL appears to be an effective, safe treatment for all stone types with comparable results.
Keywords: laser; stone composition; ureteroscopy; urinary tract calculi.
Copyright by Polish Urological Association.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Ureteroscopy and laser stone fragmentation (URSL) for large (≥1 cm) paediatric stones: Outcomes from a university teaching hospital.J Pediatr Urol. 2017 Apr;13(2):202.e1-202.e7. doi: 10.1016/j.jpurol.2016.07.006. Epub 2016 Aug 24. J Pediatr Urol. 2017. PMID: 28336220
-
Outcomes of Ureteroscopy and Laser Stone Fragmentation (URSL) for Kidney Stone Disease (KSD): Comparative Cohort Study Using MOSES Technology 60 W Laser System versus Regular Holmium 20 W Laser.J Clin Med. 2021 Jun 22;10(13):2742. doi: 10.3390/jcm10132742. J Clin Med. 2021. PMID: 34206298 Free PMC article.
-
Stone-free rate of laser lithotripsy for large pediatric stones: 15-year experience from a tertiary endourology pediatric center.Ther Adv Urol. 2025 Feb 24;17:17562872251322673. doi: 10.1177/17562872251322673. eCollection 2025 Jan-Dec. Ther Adv Urol. 2025. PMID: 40007897 Free PMC article.
-
Safety and efficacy of ureteroscopy and stone fragmentation for pediatric renal stones: a systematic review.Transl Androl Urol. 2019 Sep;8(Suppl 4):S442-S447. doi: 10.21037/tau.2019.08.23. Transl Androl Urol. 2019. PMID: 31656750 Free PMC article. Review.
-
Role of Pediatric Ureteral Access Sheath and Outcomes Related to Flexible Ureteroscopy and Laser Stone Fragmentation: A Systematic Review of Literature.Eur Urol Open Sci. 2022 Oct 12;45:90-98. doi: 10.1016/j.euros.2022.09.012. eCollection 2022 Nov. Eur Urol Open Sci. 2022. PMID: 36267473 Free PMC article. Review.
References
-
- Geraghty RM, Cook P, Walker V, Somani BK. Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years. BJU Int. 2020; 125: 586-594. - PubMed
-
- Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005; 293: 455-462. - PubMed
-
- Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005; 68: 1230-1235. - PubMed
LinkOut - more resources
Full Text Sources